A Double-Blind, Randomized Study of Clinical Efficacy of Hypothermic Therapy Following Concussion in Adolescent Athletes as Compared to a Sham-Controlled Population
A Double-Blind, Randomized Study of Clinical Efficacy of Hypothermic Therapy Following Concussion in Adolescent Athletes as Compared to a Sham-Controlled Population
This study is being conducted to determine the clinical safety and efficacy of Pro-2-Cool mediated head and neck cooling when applied after concussion and improved symptomatology among adolescent athletes as quantified by post-concussion symptom severity (PCSS) score.
This is a multi-center, prospective, randomized, double-blinded, dual-arm comparative study enrolling up to a total of 66 patients (approximately 33 patients in the treatment arm and 33 patients in the control arm) following sports-related, concussion.
Inclusion Criteria:
Males and females, 13-21 years of age
Confirmed concussion diagnosis consistent with American Congress Rehabilitation Medicine guidelines 21, without any of the following:
Glasgow Coma Scale (GCS) ≥ 13 at the time of initial injury for study enrollment.
Post-Concussion Symptom Scale Score minimum of 15
Initial provider visit is within 7 days of injury
In generally good health as confirmed by medical history and determined by site investigator or designated trained healthcare professional under the supervision of the principal investigator.
Has informed consent obtained per protocol and as required per Institutional Review Board
Exclusion Criteria:
Age < 13 years or > 21 years
Inability to understand the study requirements or provide informed consent
Cleared to return to play during initial visit
Prior participation in a Pro2Cool Clinical Study
Serious traumatic brain injury as evidenced by worsening symptoms:
Physical (e.g., head or neck injury that requires medical treatment) or mental disability hindering adequate response to assessment of symptoms
Hemodynamic instability/medical condition requiring further acute life-saving medical intervention
History of psychiatric disorder that includes suicide attempts within the last 6 months, unmanaged depression or anxiety, hospitalization for psychiatric treatment within the last 6 months
Known brain mass, intracranial hemorrhage, skull fracture
Scalp abnormalities including laceration or bleeding
Presence of ventriculoperitoneal (VP) shunt
Known hematological malignancies, including, but not limited to: multiple myeloma, leukemia, and lymphoma
Known history of Reynaud's Disease compromised liver function, cold agglutination, cold sensitivity, cryoglobulinemia, cryofibrinogenemia, and/or a history of severe migraines
Known or disclosed pregnancy or breast-feeding
Sustains another head or neck injury at the time of concussive injury which requires medical treatment
jzak@tectraum.com216-789-7676
rebecca.zickert@brightresearch.com